Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-Year results

M. S. Soloway, K. Pareek, R. Sharifi, Z. Wajsman, D. McLeod, Jr Wood, A. Puras-Baez, M. S. Austenfeld, M. K. Brawer, R. Bruskewitz, G. Chodak, S. K. Coffield, C. F. Johnson, O. E. Teague, S. Peretsman, I. Thompson, W. Cooner, H. A.G. Fisher, A. Melman, N. StoneE. Klein, B. Malkowicz, R. Middleton, P. Nieh, J. O. Peabody, J. M. Pow-Sang, S. Rous, J. Schmidt, A. Smith

Research output: Contribution to journalArticlepeer-review

280 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-Year results'. Together they form a unique fingerprint.

Medicine & Life Sciences